CVD Equipment grants director Brill 11,100 shares

Twenty-five percent vested at grant; the remaining shares vest in three installments through June 30, 2027, subject to continued director service.

Available on EDGAR 11/06/2026 - 03:09 PM EST Accepted by SEC EDGAR 11/06/2026 - 03:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CVD Equipment Corp (CVV) director Dr. Robert M. Brill received an automatic grant of 11,100 shares of Common Stock on November 5, 2026, under the previously disclosed Director Compensation Plan, with shares issued under the 2022 Share Incentive Plan. Twenty-five percent vested at grant; the remaining shares vest in equal 25% installments on December 31, 2026, March 31, 2027, and June 30, 2027, subject to his continued service as a director on each date. His direct holdings after the grant were 57,646 shares.

Insider Trade Summary

Grant/Award: 11,100 shares

Grant/Award 1 txn

Insider BRILL DR ROBERT M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	11,100	$0.00	$0.00

Holdings After Transaction: Common Stock — 57,646 shares (Direct)

Footnotes (1)

1. F1. Automatic grant issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders, pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan. Twenty-five percent of the shares were fully vested upon grant, and the remaining shares will vest in equal 25% installments on December 31, 2026, March 31, 2027 and June 30, 2027, subject to the recipient's continued service as a Director on each applicable vesting date.

Key Figures

Automatic grant: 11,100 shares Direct holdings after grant: 57,646 shares Vested upon grant: 25% +1 more

4 metrics

Automatic grant 11,100 shares Common Stock granted November 5, 2026

Direct holdings after grant 57,646 shares Dr. Robert M. Brill

Vested upon grant 25% Shares granted November 5, 2026

Each remaining vesting installment 25% Scheduled for December 31, 2026, March 31, 2027, and June 30, 2027, subject to continued director service

Key Terms

Director Compensation Plan, 2022 Share Incentive Plan, vest

3 terms

Director Compensation Plan financial

"previously disclosed Director Compensation Plan"

2022 Share Incentive Plan financial

"Common Stock issued pursuant to the Company's 2022 Share Incentive Plan"

vest financial

"remaining shares will vest in equal 25% installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did CVV director Dr. Robert M. Brill receive?

Dr. Robert M. Brill was automatically granted 11,100 shares of Common Stock on November 5, 2026. His direct holdings after the grant were 57,646 shares.

When do Dr. Robert M. Brill's CVV shares vest?

Twenty-five percent of the grant vested on November 5, 2026. The remaining shares vest in equal 25% installments on December 31, 2026, March 31, 2027, and June 30, 2027, subject to his continued service as a director on each applicable vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BRILL DR ROBERT M

(Last) (First) (Middle)

C/O CVD EQUIPMENT CORPORATION

355 S. TECHNOLOGY DRIVE

(Street)

CENTRAL ISLIP NEW YORK 11722

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVD EQUIPMENT CORP [ CVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2026		A		11,100(1)	A	$0	57,646	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Automatic grant issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders, pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan. Twenty-five percent of the shares were fully vested upon grant, and the remaining shares will vest in equal 25% installments on December 31, 2026, March 31, 2027 and June 30, 2027, subject to the recipient's continued service as a Director on each applicable vesting date.

	Robert Brill	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)